| Dec'19 | Dec'18 | Dec'17 | Dec'16 | |||
|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||
Net loss | ||||||
-12,884 | 13,938 | 1,837 | -14,202 | |||
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||
Depreciation | ||||||
6,583 | 5,867 | 5,352 | - | |||
Amortization | ||||||
2,981 | 2,421 | 2,570 | - | |||
Depreciation and amortization | ||||||
- | - | - | 8,099 | |||
Provision for losses on accounts receivable | ||||||
83 | 22 | 232 | 340 | |||
Stock-based compensation | ||||||
9,730 | 4,805 | 369 | 308 | |||
Deferred income taxes | ||||||
3,041 | -1,307 | -424 | 226 | |||
(Gain) loss on disposal of assets | ||||||
483 | -12 | -9 | 9 | |||
Loss on debt extinguishment | ||||||
0 | -12 | -911 | 0 | |||
Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | ||||||
395 | 13,734 | 3,523 | -569 | |||
Inventory | ||||||
10,670 | 6,145 | 9,875 | -8,975 | |||
Prepaid expenses and other current assets | ||||||
111 | 2,483 | 639 | -933 | |||
Other assets | ||||||
2,669 | 2,262 | 1,148 | 3,069 | |||
Accounts payable | ||||||
844 | 172 | 2,491 | 601 | |||
Accrued and other long-term liabilities | ||||||
92 | -310 | 3,160 | 3,038 | |||
Deferred revenues | ||||||
-178 | -215 | 731 | -223 | |||
Deferred revenue | ||||||
- | - | - | -243 | |||
Non-current income taxes payable | ||||||
-205 | 2,542 | 1,358 | 616 | |||
Net cash used in operating activities | ||||||
-4,241 | 3,335 | 3,411 | 5,959 | |||
Cash flows from investing activities: | ||||||
Acquisition of business, net of cash acquired | ||||||
17,400 | 0 | 0 | - | |||
Purchases of property, equipment and patents | ||||||
13,632 | 11,714 | 5,483 | 4,063 | |||
Proceeds from sale of assets | ||||||
628 | 35 | 6 | 36 | |||
Net cash used in investing activities | ||||||
-30,404 | -11,679 | -5,477 | -4,027 | |||
Cash flows from financing activities: | ||||||
Principal payments on debt and capital leases | ||||||
55 | 33,417 | 15,318 | 8,331 | |||
Net proceeds from debt financing | ||||||
0 | 16,053 | 12,499 | 0 | |||
Cash paid on debt extinguishment | ||||||
0 | 0 | 388 | 0 | |||
Proceeds from public offerings, net of offering costs | ||||||
0 | 138,303 | 0 | 0 | |||
Proceeds from issuance of convertible preferred stock | ||||||
0 | 0 | 27,481 | 11,964 | |||
Proceeds from employee stock plan purchases | ||||||
1,471 | 0 | 0 | - | |||
Payments of other financing costs | ||||||
0 | 0 | 191 | 44 | |||
Proceeds from stock option exercises | ||||||
1,560 | 362 | 336 | 52 | |||
Tax payments related to stock award issuances | ||||||
524 | 0 | 0 | - | |||
Net cash provided by financing activities | ||||||
2,452 | 121,301 | 24,419 | 3,641 | |||
Effect of exchange rate changes on cash | ||||||
-33 | -166 | 834 | 1,072 | |||
Net decrease in cash and cash equivalents | ||||||
-32,226 | 112,791 | 23,187 | 6,645 | |||
Supplemental disclosures: | ||||||
Cash received for interest | ||||||
-2,802 | 941 | 1,437 | 2,060 | |||
Cash paid for income taxes | ||||||
2,335 | 3,665 | 3,493 | 1,271 | |||
Accrued purchases of property, equipment and patents | ||||||
828 | 577 | 969 | 0 | |||
Supplemental disclosures of noncash investing and financing activities: | ||||||
Accrued deferred offering costs | ||||||
0 | 0 | 530 | 0 | |||